ARTICLES

Rival drug maker offers $29B for Perrigo

April 8, 2015
In a deal that would combine two rival companies that recently left the U.S. for Europe, a generic drug maker said it wants to buy Perrigo for $205 per share, or $28.86 billion. Read More